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Background: Conventional understanding of obesity demonstrates negative consequences to 
overall health, while more modern studies have found that it can provide certain 
advantages. Current literature on the effect of body mass index (BMI) in subarachnoid 
hemorrhage (SAH) is similarly inconsistent. 
Methods: 406 patients with SAH were retrospectively reviewed and stratified into three BMI 
categories: normal weight between 18.5 and 24.9 kg/m2; overweight between 25 and 29.9 
kg/m2; and obese greater than 30 kg/m2. Neurologic status, the presence of clinical 
cerebral vasospasm, and outcome as assessed by the modified Rankin scale (mRS) were 
obtained.  
Results: Statistical differences were evident for all outcome categories. A categorical analysis of 
the different groups revealed that, compared to the normal weight BMI, the overweight 
group had an odds ratio for mortality of 0.415 (p = 0.023), poor mRS at 90 days of 0.432 
(p = 0.014), and poor mRS at 180 days of 0.311 (p = 0.001). The obese group had a 
statistically significant odds ratio for poor mRS at 90 days of 2.067 (p = 0.041) and at 
180 days of 1.947 (p = 0.049). These significant odds ratios persisted in a multivariable 
model controlling for age and Hunt & Hess grade.   
Conclusions: The overweight BMI group exhibited a striking decrease for the odds of death and 
poor outcome compared to the normal weight BMI, whereas the obese group 
demonstrated the contrary. These associations persisted in a multivariable model, thus 








 Obesity has long been associated with several diseases such as stroke, diabetes, and heart 
disease, in which it not only increases morbidity in these pathological conditions, but also 
mortality.1-4 In addition, patients who are obese are more likely to experience in hospital 
complications such as venous thromboembolism and infection, and have longer intensive care 
unit (ICU) stays.5-8 However, recent studies have shown that an increased body mass index 
(BMI) may lend a protective effect in certain diseases.9,10 This “obesity paradox” is contrary to 
conventional wisdom and may actually be beneficial in coronary artery disease, acute myocardial 
infarction, and stroke.11-13 An understanding of how the accumulation of excess body fat 
influences health is still being revised. For example, one study showed that being in an 
overweight BMI reduced the risk of mortality compared to those who were obese.14 It has been 
posited that the increased energy reserves of overweight and obese patients allow them to 
tolerate severe disease. The new data has encouraged research regarding the protective versus 
detrimental effect of obesity in various disease states. These studies will be extremely relevant 
given the increasing prevalence of obesity in the US and across the world. 
 Subarachnoid hemorrhage (SAH) is a devastating disease with an initial mortality of 
50%. The effects of obesity on post-bleed outcomes in SAH have previously been studied but the 
relationship between the two is unclear. Some studies have found that obesity leads to a 
decreased overall mortality but a higher risk of delayed cerebral ischemia (DCI), which can 
independently increase morbidity.15,16 One study found that obesity increased the risk of ICU 
related complications.17 Still, some authors have found no differences in outcome for obese and 
non-obese patients who presented with SAH.18-20 Further research is needed to determine the 





database of patients with SAH from a single urban institution to evaluate the effects of BMI on 
severity of SAH, complications during the hospital course, and both short and long-term 
outcomes. 
 
Materials and Methods 
Patients 
 After obtaining approval from the institutional review board, we acquired charts of 
patients who presented at a single academic institution with aneurysmal subarachnoid 
hemorrhage between 2007 and 2017. We obtained demographic information and neurologic 
status on admission assessed by the Hunt & Hess (H&H) grade, the modified Fisher grade, the 
presence of radiographic cerebral vasospasm, the presence of clinical cerebral vasospasm, and 
outcome as assessed by the modified Rankin scale (mRS).  
 The patient’s BMI was calculated by the weight in kilograms divided by the height in 
meters squared. We grouped the patients into three categories according to World Health 
Organization classification: normal weight, 18.5 and 24.9 kg/m2; overweight, between 25 and 
29.9 kg/m2; and obese, greater than 30 kg/m2.21 Patients were excluded from the study if they 
had missing data points and did not follow up at 6 months.  
 
Outcome 
 Primary outcomes were measured using the mRS stratified into three time frames: 
hospital discharge, 90 days, and 180 days post hemorrhage. A poor mRS was defined as a score 
≥ 4. The assessments were made via a standardized patient interview during an outpatient follow 





presentation, the modified Fisher score, the method of aneurysm treatment (surgical vs. 
endovascular), and the presence of cerebral vasospasm. A poor H&H grade was defined as being 
≥ 4 and a poor modified Fisher score was defined as being ≥ 3.  
 
Statistical Analysis 
 All statistical analyses were performed using SPSS version 24 (IBM Corporation, 
Armonk, NY) for Macintosh, with a P value of ≤ 0.05 as our threshold for statistical 
significance. Kruskal-Wallis H tests, analysis of variances, and Pearson chi-square tests were 
used to assess differences in patient demographics and outcomes. On univariate analysis the 
associations between BMI and age, H&H grade, anterior or posterior aneurysm location, 
aneurysm size, DCI, and rebleed rate with mortality and mRS at 90 and 180 days were done with 
a bivariate correlation using the Spearman’s test with BMI as a continuous variable and the 
Kruskal-Wallis H test with BMI as a categorical variable. Multivariate analysis of BMI as 
categorical values was done using a logistic regression model with calculated odds ratios (OR) 




 406 patients diagnosed with SAH were identified using the above-mentioned criteria. 
Patient demographic and admission data were divided among the three BMI classifications and is 
listed in Table 1. 122 patients (30%) were classified in the normal weight category, 154 (38%) in 
the overweight category, and 130 (32%) in the obese category. There was a significant difference 





(21.5-24.3); overweight, 26.9 (25.8-28.5); and obese, 34.2 (31.4-37.8) (p = .001). There were no 
significant differences for age, sex, nicotine users, median H&H grade, modified Fisher grade, 
aneurysm location, aneurysm size, intraventricular hemorrhage, radiographic vasospasm, 
treatment modalities, or hospital course.     
 
Outcomes 
 Patient outcomes are listed in Table 2. Among the three groups, there were significant 
differences for mortality at discharge (32.8%, 16.8%, and 29.3, respectively: p = .048), poor 
mRS at discharge (49.2%, 29.5%, 66.7%, respectively: p = .001), poor mRS at 90 days (49.2%, 
23.2%, 65.3%, respectively: p = .001), and poor mRS at 180 days (45.9%, 17.9%, 59.7%, 
respectively: p = .001).  
 
Subgroup Analyses 
 The evaluation of both BMI as a continuous and categorical variable along with patient 
demographic information and admission data related to the initial SAH severity compared to 
outcomes on univariate analysis is listed in Table 3 and Table 4. Age, a poor H&H grade, a poor 
modified Fisher score, and DCI were significantly correlated to mortality at discharge and poor 
mRS at 90 and 180 days. An anterior circulation aneurysm location, aneurysm size, and rebleed 
rate were not correlated.  
 As a continuous variable, BMI was not significantly associated with mortality at 
discharge (OR: 1.002, 95% CI: 0.954-1.053, p = .932), but a significant association existed for a 
poor mRS at both 90 days (OR: 1.050, 95% CI: 1.004-1.098, p = .031) and 180 days (OR: 1.048, 





an overweight BMI was significantly associated with a lower mortality (OR: 0.415, 95% CI: 
0.195-0.886, p = .023), and less of a risk for a poor mRS at 90 days (OR: 0.432, 95% CI: 0.221-
0.842, p = .014), and at 180 days (OR: 0.311, 95% CI: 0.156-0.622, p = .001). The obese BMI 
when compared to the normal weight category was not significantly associated for mortality but 
was for poor mRS at 90 days (OR: 2.067, 95% CI: 1.032-4.139, p = .041) and poor mRS at 180 
days (OR: 1.947, 95% CI: 1.105-3.888, p = .049). 
 Multivariate analysis with BMI as categorical variables along with the significant 
univariate associations is listed in Table 5. Age and a poor H&H grade remained significantly 
associated to mortality, and poor mRS at 90 and 180 days, whereas a poor modified Fisher score 
and DCI was not significant. Compared to the normal weight BMI in the multivariable model 
including age and H&H grade, the overweight BMI was significantly associated with a better 
mortality (OR: 0.309, 95% CI: 0.102-0.937, p = .038), less of a risk for a poor mRS at 90 days 
(OR: 0.243, 95% CI: 0.085-0.692, p = .008), and poor mRS at 180 days (OR: 0.122, 95% CI: 
0.039-0.383, p = .001). The obese BMI when compared to the normal weight category in the 
multivariable model was significantly associated with poor mRS at 90 days (OR: 5.064, 95% CI: 
1.753-14.627, p = .003) and poor mRS at 180 days (OR: 2.918, 95% CI: 1.036-8.220, p = .043). 
 
Discussion 
 Our conventional understanding of the systemic effects of obesity would lead us to 
believe that BMI directly influences worsened mortality and morbidity, which could be 
applicable to patients with SAH. A study from 2005 found that there was a 1.15 (95% CI: 1.02–





In a recent study, Elliott et al. found that morbid obesity (BMI greater than 40 kg/m2) was 
associated with an increased length of stay, hospital costs, and acute respiratory failure.22
 Lately, the notion of an “obesity paradox” has begun to redefine our knowledge of the 
effects of obesity. For patients with first time acute stroke, one study found that in a cohort of 
2785 obese and overweight patients, short and long-term survival was better at one week, one 
month, and 10 years.13 However for patients with SAH, a study found that patients with a lower 
BMI also had a lower mRS.20 Hughes et al. found evidence of the obesity paradox in 281 
patients for mortality but not for functional outcome in both univariate and multivariate 
analyses.15 Interestingly, in Elliott et al.’s aforementioned study that found a detrimental 
association between morbid obesity and ICU length of stay, hospital costs, and acute respiratory 
failure, the group’s multivariate analysis demonstrated that obesity had a converse impact on 
mortality with an OR of 0.83 (95% CI: 0.74-0.92).22   
 Still, many studies have reported no association between obesity and outcome.18,19,23 In 
an analysis of 741 patients with SAH, one study found that the median BMI was higher in 
patients with a more severe Glasgow Outcome Scale value; however, this did not persist in a 
multivariate analysis.18 Kagerbauer et al.’s study found no association between BMI and poor 
neurological outcome in aneurysmal SAH.19 Finally, an analysis of 2695 patients in the tirilazad 
trial database across many different countries did not find a significant association between 
patient weight and poor outcome on univariate anaylsis.23  
 Based on the current literature, a general consensus does not exist on the effect of BMI 
on SAH. A seemingly equal share of studies exist that show how obesity can be detrimental, 
protective, or have no effect on morbidity and mortality after SAH. This is further complicated 





having a greater influence on the latter. While most studies do not examine mortality as a 
primary endpoint, and rather examine functional outcome at 6 months, this could also be due to 
the inherent physiology of obesity. Proponents of the obesity paradox have suggested that the 
readily available nutritional and caloric energy stockpiles can lend to the protective effect of 
obesity after a severe insult to the body, such as in SAH.15,24 Conversely, others have postulated 
that the prolonged multifactorial damage caused by obesity severely decreases the ability to 
mount an adequate response to acute injury, and that an obesity paradox is due to confounding 
variables.10,15 This disparity is furthered by the multitude of conflicting reports in the literature.   
 Our data of 406 patients after SAH supports the idea of an obesity paradox to an 
interesting extent. Framing BMI as a continuous variable in our univariate analysis shows a 
significant association with a poor mRS at 90 and 180 days, whereas there is no association to 
mortality. Nevertheless, the risk for a poor mRS at these time points (OR: 1.050 and 1.048) is 
relatively negligible. Stratifying BMI using the conventional World Health Organization 
classification system reveals that when compared to the normal weight BMI, both the overweight 
and obese groups have inverse associations with mortality and functional outcome. Patients with 
an overweight BMI were 58.5% less likely to have died, 56.8% less likely to have had a poor 
mRS at 90 days, and 68.9% less likely to have had a poor mRS at 180 days when compared to 
those with a normal weight. For the obese group, the risk for a poor functional outcome at 90 and 
180 days were approximately twofold (OR: 2.067 and 1.947) higher than the normal weight 
BMI.  
 The distinction between using BMI as a categorical variable compared to just a 
continuous one reveals an important trend in our univariate results. At face value, BMI as 





overweight group compared to a normal weight group. This profoundly impacts our study 
because it could help support the notion of an obesity paradox that would not be readily 
apparent. BMI as a categorical variable also neatly packages the concept in to one that is well 
known and commonly used.   
 A multivariable model including age and H&H grade was used to further determine the 
effect BMI has on mortality and morbidity. These two factors, along with a poor modified 
Fischer score and DCI, were significantly associated with mortality and poor mRS in our 
univariate analysis, but the modified Fisher score and DCI dropped out in the analysis. The 
overweight group had a 69.1% less risk of mortality, a 75.7% less risk for poor outcome at 90 
days, and an 87.8% less risk for poor outcome at 180 days compared to the normal weight group. 
Conversely, the obese group was 406.4% more likely to have a poor outcome at 90 days and 
191.8% more likely to have a poor outcome at 180 days compared to the normal weight BMI. 
Mortality was not significantly different between the obese and normal weight group for this 
model.  
 These results demonstrate that being overweight could lend a protective effect after SAH, 
but tipping the scale to a higher BMI in the obese category could be detrimental. Our results 
seem to support the two major tenets of the obesity paradox; a surplus of calories and essential 
micronutrients can potentially cushion the devastating consequences after SAH, yet a critical 
point is reached where the physiologic detriment associated with obesity negates these benefits. 
One theory is that since the amount of visceral adiposity decreases with age, older patients 
possess an obesity that is inherently less risky.25 Since age is an independent morbidity risk 
factor for SAH, this etiology may be especially relevant. Additionally, the obesity paradox may 





measures of body habitus such as waist circumference may be more relevant in SAH. Previously, 
obese patients have been shown to have greater vascular function, including flow-mediated 
dilation, due to better mobilization of endothelial progenitor cells.26 Finally, obesity has been 
associated with increased levels of circulating coagulation factors such as factor VII, factor VIII, 
and fibrinogen, which may allow for more rapid coagulation during the ictal SAH hemorrhagic 
event.27 Our results also reinforce the importance of a strict and rigorous post-SAH nutrition 
rehabilitation plan.   
 Along with the usual limitations of any retrospective study, one weakness of this study 
was the lack of inclusion of comorbid conditions. This would skew more towards the obese 
category but would not rationalize the results seen for the overweight BMI. Also, while the BMI 
categorization provides an easily quantifiable way to stratify patients in terms of risks for 
mortality and morbidities, it has been criticized for not fully for assessing nutritional or caloric 
status, which could be done by other means.  
 
Conclusions 
 This study was used to clarify the influence BMI has on SAH outcomes. The overweight 
group exhibited a striking decrease for the odds of death and poor outcome compared to the 
normal weight category. In contrast, the obese group had an increased risk of death and poor 
outcome. These associations persisted in a multivariable model including age and H&H grade, 
thus BMI is an independent predictor of outcome after SAH.  
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Table 1. Patient demographic and admission data relating to subarachnoid hemorrhage by body mass index categories  
 
   
BMI Categories 
 
Category Parameter Total 
Normal 
18.5 - 24.9 
kg/m2 
Overweight 
25 - 29.9 kg/m2 
Obese 
≥ 30 kg/m2 
p 
Demographics 
Median BMI (kg/m2) (IQR) 27.2 (24.9-31.3) 23.1 (21.5-24.3) 26.9 (25.8-28.5) 34.2 (31.4-37.8) .001* 
Mean Age (years) ± SD 52.77 ± 14.3 55.33 ± 15.9 52.29 ± 12.5 51.29 ± 14.8 .24 
Female % 70.1 72.1 70.5 68 .867 
Nicotine Users % 42.7 45.5 44.3 38.2 .054 




Median Hunt & Hess Grade (IQR) 3 (2-4) 3 (2-4) 3 (1-4) 3 (2-4) .71 
Modified Fisher Grade ≥ 3 % 79.9 86.3 76.2 79.7 .366 
Anterior Aneurysm Location % 58.1 58.2 61.2 56.6 .076 
Aneurysm Size (mm) ± SD 6.77 ± 3.1 6.42 ± 3.4 6.93 ± 2.9 7.01 ± 3.2 .619 
Intraventricular Hemorrhage % 77.9 80.3 72.6 82.7 .255 
Radiographic Vasospasm % 42.5 41.2 44.4 43.5 .354 
       
Treatment 
Coil % 61.2 61.7 62.3 60.3 .409 
EVD % 68.4 69.5 67.7 67 .349 
VP Shunt % 17.2 14 19.1 16.5 .204 
       
Hospital 
Course 
Rebleed % 6.5 8.2 5.3 6.7 .766 
DCI % 60.6 60.7 56.8 65.3 .531 
Seizure % 5.7 4.9 7.4 4.2 .633 
Median Hospital Length of Stay 
(IQR) 
13 (10-20) 12 (8-20) 13 (10-18) 14 (11-20) .694 
 
BMI: body mass index; IQR: interquartile range; SD: standard deviation; EVD: external ventricular drain; VP: ventriculoperitoneal; 
DCI: delayed cerebral ischemia; * = significant p < 0.05 
 








18.5 - 24.9 kg/m2 
Overweight 
25 - 29.9 kg/m2 
Obese 
≥ 30 kg/m2 
p 
Mortality at Discharge % 25.1 32.8 16.8 29.3 .048* 
Poor mRS (≥ 4) at Discharge % 46.8 49.2 29.5 66.7 .001* 
Poor mRS (≥ 4) at 90 days % 43.7 49.2 23.2 65.3 .001* 
Poor mRS (≥ 4) at 180 days % 38.5 45.9 17.9 58.7 .001* 
 
BMI: body mass index; mRS: modified Rankin scale; * = significant p < 0.05 
 




Mortality  Poor mRS (≥4) at 90 days  Poor mRS (≥4) at 180 days 
 
OR (95% CI) p  OR (95% CI) p  OR (95% CI) p 
Age 1.081 (1.054-1.109) .001*  1.056 (1.034-1.078) .001*  1.061 (1.038-1.084) .001* 
Hunt & Hess Grade (≥ 4) 10.944 (5.554-21.565) .001*  8.473 (4.318-16.628) .001*  8.134 (4.254-15.550) .001* 
Modified Fisher Grade (≥ 3) 20.901 (2.802-55.92) .003*  3.368 (1.553-7.303) .002*  3.708 (1.618-8.498) .002* 
Anterior Aneurysm Location 1.001 (0.50-1.20) .88  1.003 (0.54-2.99) .51  1.02 (0.546-2.22) .729 
Aneurysm Size 1.050 (0.333-1.04) .732  1.054 (0.39-1.099) .766  1.063 (0.44-1.055) .865 
DCI 2.000 (1.075-3.720) .029*  2.242 (1.325-3.792) .003*  2.469 (1.447-4.211) .001* 
Rebleed 1.310 (0.437-3.926) .63  1.063 (0.386-2.929) .906  1.202 (0.436-3.313) .722 
 
mRS: modified Rankin scale; OR: odds ratio; CI: confidence interval; DCI: delayed cerebral ischemia; * = significant p < 0.05 
 




Mortality  Poor mRS (≥4) at 90 days  Poor mRS (≥4) at 180 days 
 
OR (95% CI) p  OR (95% CI) p  OR (95% CI) p 







Overweight 0.415 (0.195-0.886) .023*  0.432 (0.221-0.842) .014*  0.311 (0.156-0.622) .001* 
Obese 0.851 (0.410-1.766) .665  2.067 (1.032-4.139) .041*  1.947 (1.105-3.888) .049* 
  
mRS: modified Rankin scale; OR: odds ratio; CI: confidence interval; BMI: body mass index; * = significant p < 0.05 
 




mRS: modified Rankin scale; OR: odds ratio; CI: confidence interval; DCI: delayed cerebral ischemia; BMI: body mass index; * = 
significant p < 0.05 
 
 
Mortality  Poor mRS (≥4) at 90 days  Poor mRS (≥4) at 180 days 
 
OR (95% CI) p  OR (95% CI) p  OR (95% CI) p 
Age 1.084 (1.049-1.120) .001*  1.100 (1.061-1.141) .001*  1.099 (1.060-1.140) .001* 










Modified Fisher Grade (≥ 
3) 
3.661 (0.438-30.600) .113 
 
0.777 (0.272-2.214) .636 
 
0.700 (0.229-2.139) .532 







Overweight 0.309 (0.102-0.937) .038*  0.243 (0.085-0.692) .008*  0.122 (0.039-0.383) .001* 
Obese - -  5.064 (1.753-14.627) .003*  2.918 (1.036-8.220) .043* 
Abbreviation List 
BMI: Body Mass Index 
CI: Confidence Interval 
CT: Computed Tomography 
DCI: Delayed Cerebral Ischemia 
EVD: External Ventricular Drain 
H&H: Hunt & Hess  
ICU: Intensive Care Unit 
IQR: Interquartile Range 
mRS: Modified Rankin scale 
OR: Odds ratio 
SAH: Subarachnoid Hemorrhage 
SD: Standard Deviation 
VP: Ventriculoperitoneal 
